Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Biliary Tract Diseases

Free Subscription Articles published in J Gastroenterol Retrieve available abstracts of 29 articles: HTML format

Single Articles

November 2024
1. HAO Z, Lu Y, Hao Y, Luo Y, et al
   Fungal mycobiome dysbiosis in choledocholithiasis concurrent with cholangitis.
   J Gastroenterol. 2024 Nov 27. doi: 10.1007/s00535-024-02183.
   PubMed     Abstract available
   
   
   
2. YASUDA M, Shiokawa M, Kuwada T, Nishikawa Y, et al
   Anti-integrin alphavbeta6 autoantibody in primary sclerosing cholangitis: a Japanese nationwide study.
   J Gastroenterol. 2024 Nov 16. doi: 10.1007/s00535-024-02169.
   PubMed     Abstract available
   
   
   
3. CAO Z, Yang Y, Liu S, Sun L, et al
   FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma.
   J Gastroenterol. 2024 Nov 13. doi: 10.1007/s00535-024-02175.
   PubMed     Abstract available
   
   
   August 2024
4. TAKAOKA S, Hamada T, Nakai Y, Yasunaga H, et al
   Response to the letter by Buldukoglu et al. regarding our manuscript "Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-based validation".
   J Gastroenterol. 2024 Aug 6. doi: 10.1007/s00535-024-02143.
   PubMed    
   
   
   July 2024
5. AMPUERO J, Aller R, Gallego-Duran R, Crespo J, et al
   The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis.
   J Gastroenterol. 2024;59:586-597.
   PubMed     Abstract available
   
   
   June 2024
6. TAKAOKA S, Hamada T, Takahara N, Fukuda R, et al
   Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-based validation.
   J Gastroenterol. 2024 Jun 19. doi: 10.1007/s00535-024-02124.
   PubMed     Abstract available
   
   
   May 2024
7. KANO Y, Ishikawa T, Yamao K, Mizutani Y, et al
   What is the appropriate method of pathological specimen collection for cholangiocarcinoma detection in primary sclerosing cholangitis?
   J Gastroenterol. 2024 May 7. doi: 10.1007/s00535-024-02105.
   PubMed     Abstract available
   
   
   March 2024
8. XIN HY, Zou JX, Sun RQ, Hu ZQ, et al
   Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma.
   J Gastroenterol. 2024 Mar 10. doi: 10.1007/s00535-024-02090.
   PubMed     Abstract available
   
   
   October 2023
9. WU JF, Peng SS, Tai CS, Lin WH, et al
   The magnetic resonance imaging and age-adjusted matrix metalloproteinase-7 assist the diagnosis of biliary atresia.
   J Gastroenterol. 2023 Oct 30. doi: 10.1007/s00535-023-02051.
   PubMed     Abstract available
   
   
   
10. WANG H, Li Y, Pu X, Liang X, et al
    MGAT5/TMEM163 variant is associated with prognosis in ursodeoxycholic acid-treated patients with primary biliary cholangitis.
    J Gastroenterol. 2023 Oct 16. doi: 10.1007/s00535-023-02045.
    PubMed     Abstract available
    
    
    September 2023
11. OZONO Y, Kawakami H, Uchiyama N, Hatada H, et al
    Current status and issues in genomic analysis using EUS-FNA/FNB specimens in hepatobiliary-pancreatic cancers.
    J Gastroenterol. 2023 Sep 12. doi: 10.1007/s00535-023-02037.
    PubMed     Abstract available
    
    
    July 2023
12. FUJITA N, Yasuda I, Endo I, Isayama H, et al
    Evidence-based clinical practice guidelines for cholelithiasis 2021.
    J Gastroenterol. 2023 Jul 15. doi: 10.1007/s00535-023-02014.
    PubMed     Abstract available
    
    
    
13. PENG M, Li H, Cao H, Huang Y, et al
    Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma.
    J Gastroenterol. 2023 Jul 11. doi: 10.1007/s00535-023-02012.
    PubMed     Abstract available
    
    
    June 2023
14. XU H, Lin X, Li Z, He X, et al
    VIRMA facilitates intrahepatic cholangiocarcinoma progression through epigenetic augmentation of TMED2 and PARD3B mRNA stabilization.
    J Gastroenterol. 2023 Jun 30. doi: 10.1007/s00535-023-02015.
    PubMed     Abstract available
    
    
    
15. YOSHIDA H, Shiokawa M, Kuwada T, Muramoto Y, et al
    Anti-integrin alphavbeta6 autoantibodies in patients with primary sclerosing cholangitis.
    J Gastroenterol. 2023 Jun 13. doi: 10.1007/s00535-023-02006.
    PubMed     Abstract available
    
    
    May 2023
16. KIM KA, Choi HY, Ki M, Jang ES, et al
    Epidemiological trends and outcomes of primary biliary cholangitis in South Korea between 2009 and 2019.
    J Gastroenterol. 2023 May 17. doi: 10.1007/s00535-023-01999.
    PubMed     Abstract available
    
    
    December 2022
17. SATAKE T, Morizane C, Rikitake R, Higashi T, et al
    Correction: The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry.
    J Gastroenterol. 2022 Dec 23. doi: 10.1007/s00535-022-01944.
    PubMed    
    
    
    September 2022
18. SATAKE T, Morizane C, Rikitake R, Higashi T, et al
    The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry.
    J Gastroenterol. 2022 Sep 26. pii: 10.1007/s00535-022-01920.
    PubMed     Abstract available
    
    
    
19. ARIZUMI T, Tazuma S, Isayama H, Nakazawa T, et al
    Ursodeoxycholic acid is associated with improved long-term outcome in patients with primary sclerosing cholangitis.
    J Gastroenterol. 2022 Sep 6. pii: 10.1007/s00535-022-01914.
    PubMed     Abstract available
    
    
    July 2022
20. KODAMA K, Kawaoka T, Kosaka M, Johira Y, et al
    Calcium channel blockers improve the prognosis of patients with intrahepatic cholangiocarcinoma after resection.
    J Gastroenterol. 2022 Jul 18. pii: 10.1007/s00535-022-01887.
    PubMed     Abstract available
    
    
    June 2022
21. MULLIRI A, Menahem B, Alves A, Dupont B, et al
    Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials.
    J Gastroenterol. 2022 Jun 15. pii: 10.1007/s00535-022-01886.
    PubMed     Abstract available
    
    
    April 2022
22. MORI Y, Okawara M, Fujimoto K, Oba T, et al
    Evaluation of cholecystectomy in older individuals using real-world data: a multilevel analysis based on a nationwide administrative database in Japan.
    J Gastroenterol. 2022 Apr 12. pii: 10.1007/s00535-022-01873.
    PubMed     Abstract available
    
    
    March 2022
23. SUZUKI Y, Mori T, Momose H, Matsuki R, et al
    Predictive factors for subsequent intrahepatic cholangiocarcinoma associated with hepatolithiasis: Japanese National Cohort Study for 18 years.
    J Gastroenterol. 2022 Mar 31. pii: 10.1007/s00535-022-01868.
    PubMed     Abstract available
    
    
    
24. ISAYAMA H, Tazuma S, Kokudo N, Tanaka A, et al
    Correction to: Clinical guidelines for primary sclerosing cholangitis 2017.
    J Gastroenterol. 2022 Mar 16. pii: 10.1007/s00535-022-01867.
    PubMed    
    
    
    December 2021
25. BURGHART L, Halilbasic E, Schwabl P, Simbrunner B, et al
    Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis.
    J Gastroenterol. 2021 Dec 11. pii: 10.1007/s00535-021-01839.
    PubMed     Abstract available
    
    
    November 2021
26. MATSUMOTO K, Ohfuji S, Abe M, Komori A, et al
    Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case-control study.
    J Gastroenterol. 2021 Nov 18. pii: 10.1007/s00535-021-01836.
    PubMed     Abstract available
    
    
    December 2020
27. MARUKI Y, Morizane C, Arai Y, Ikeda M, et al
    Correction to: Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study).
    J Gastroenterol. 2020 Dec 30. pii: 10.1007/s00535-020-01755.
    PubMed    
    
    
    October 2020
28. MARUKI Y, Morizane C, Arai Y, Ikeda M, et al
    Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study).
    J Gastroenterol. 2020 Oct 26. pii: 10.1007/s00535-020-01735.
    PubMed     Abstract available
    
    
    
29. YU WL, Yu G, Dong H, Chen K, et al
    Proteomics analysis identified TPI1 as a novel biomarker for predicting recurrence of intrahepatic cholangiocarcinoma.
    J Gastroenterol. 2020 Oct 21. pii: 10.1007/s00535-020-01729.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Biliary Tract Diseases is free of charge.